OncoMed Pharmaceuticals

📍 Redwood City, United States🗓 Founded 2004👥 34 employees💰 Last funded Jun 2006
Biotechnology Research🌐 oncomed.com
Website LinkedIn
OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline. Since our founding in August 2004, we have raised more than $600 million, more than half of which has come from collaboration funding from our pharmaceutical partnerships.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2004
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in OncoMed Pharmaceuticals?
OncoMed Pharmaceuticals has 1 investors on record on gritt.io, including 1 early-stage backers.
When did OncoMed Pharmaceuticals last raise funding?
The most recent investment in OncoMed Pharmaceuticals recorded on gritt.io was in June 2006.
When was OncoMed Pharmaceuticals founded?
OncoMed Pharmaceuticals was founded in 2004.
What industry is OncoMed Pharmaceuticals in?
OncoMed Pharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is OncoMed Pharmaceuticals based?
OncoMed Pharmaceuticals is headquartered in Redwood City, United States.